INTELLIA THERAPEUTICS INC (NTLA)
US45826J1051 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to NTLA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 60.18. This target is 394.09% above the current price.
NTLA was analyzed by 35 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NTLA.
In the previous month the buy percentage consensus was at a similar level.
NTLA was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-18 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-11-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-25 | Baird | Maintains | Neutral -> Neutral |
| 2024-10-25 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-10-25 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-10-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-17 | Jones Trading | Initiate | Buy |
| 2024-09-11 | Stifel | Maintains | Buy -> Buy |
| 2024-08-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-24 | Truist Securities | Maintains | Buy -> Buy |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-10 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-05-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-04-23 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-02-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-23 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2024-02-15 | Wolfe Research | Initiate | Peer Perform |
| 2023-11-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-10 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-10 | RBC Capital | Maintains | Outperform -> Outperform |